Medical Technology - Czechia

  • Czechia
  • In Czechia, the projected revenue in the Medical Technology market market for 2024 is estimated to reach US$2.12bn.
  • The largest market within this market is Medical Devices, which is expected to have a projected market volume of US$1.77bn in 2024.
  • Looking ahead, the revenue is predicted to demonstrate an annual growth rate (CAGR 2024-2029) of 4.64%, leading to a market volume of US$2.66bn by 2029.
  • When compared globally, the United States is expected to generate the highest revenue in 2024, amounting to US$211.10bn.
  • Czechia's medical technology market is rapidly expanding, with a focus on innovative solutions for precision medicine and telehealth.

Key regions: United States, Germany, China, Japan, France

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Medical Technology market in Czechia is experiencing significant growth and development due to several key factors. Customer preferences for advanced healthcare solutions, increasing demand for medical devices, and local special circumstances are driving this trend. Additionally, underlying macroeconomic factors are contributing to the growth of the Medical Technology market in Czechia. Customer preferences in Czechia are shifting towards advanced healthcare solutions and medical devices. Patients are increasingly seeking innovative and technologically advanced medical equipment and treatments. This preference is driven by the desire for more accurate diagnoses, less invasive procedures, and improved patient outcomes. As a result, there is a growing demand for medical technology products and services in the country. Trends in the market reflect the increasing demand for medical devices and healthcare solutions in Czechia. The market is witnessing a rise in the adoption of digital health technologies, such as telemedicine and remote patient monitoring. These technologies enable healthcare professionals to provide medical care and monitor patients remotely, improving access to healthcare services and reducing the burden on hospitals and clinics. Additionally, there is a growing focus on personalized medicine, with advancements in genetic testing and precision medicine driving the development of targeted therapies. Local special circumstances in Czechia are also contributing to the growth of the Medical Technology market. The country has a well-developed healthcare system with a high standard of care, which creates a favorable environment for the adoption of medical technology. Furthermore, Czechia has a strong manufacturing sector, including medical device manufacturing, which supports the local production and export of medical technology products. Underlying macroeconomic factors are playing a significant role in the development of the Medical Technology market in Czechia. The country has a stable economy with a strong focus on innovation and technology. This provides a conducive environment for the growth of the medical technology sector, attracting investment and fostering research and development. Additionally, the government's support for healthcare modernization and the implementation of digital health initiatives further drive the growth of the market. In conclusion, the Medical Technology market in Czechia is experiencing growth and development due to customer preferences for advanced healthcare solutions, increasing demand for medical devices, local special circumstances, and underlying macroeconomic factors. The market is witnessing a rise in the adoption of digital health technologies and personalized medicine, driven by the desire for improved patient outcomes and access to healthcare services. The country's well-developed healthcare system, strong manufacturing sector, stable economy, and government support for healthcare modernization contribute to the growth of the market.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)